no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report
|
Iguchi, Toyotaka |
|
|
44 |
11 |
p. 1209-1214 |
article |
2 |
Desloratadine Exposure and Incidence of Seizure: A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001–2015
|
Ersbøll, Annette Kjær |
|
|
44 |
11 |
p. 1231-1242 |
article |
3 |
Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature
|
Clinton, Joseph William |
|
|
44 |
11 |
p. 1125-1149 |
article |
4 |
Identifying Actionability as a Key Factor for the Adoption of ‘Intelligent’ Systems for Drug Safety: Lessons Learned from a User-Centred Design Approach
|
Gavriilidis, George I. |
|
|
44 |
11 |
p. 1165-1178 |
article |
5 |
Inconsistent Safety Outcome Reporting in Randomized Clinical Trials of COVID-19 Vaccines Complicates Informed Medical Decisions
|
Blais, Joseph E. |
|
|
44 |
11 |
p. 1121-1123 |
article |
6 |
Role of Drug–Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity
|
Jessurun, Naomi T. |
|
|
44 |
11 |
p. 1179-1191 |
article |
7 |
Surveillance of Antidepressant Safety (SADS): Active Signal Detection of Serious Medical Events Following SSRI and SNRI Initiation Using Big Healthcare Data
|
Aakjær, Mia |
|
|
44 |
11 |
p. 1215-1230 |
article |
8 |
Systematising Pharmacovigilance Engagement of Patients, Healthcare Professionals and Regulators: A Practical Decision Guide Derived from the International Risk Governance Framework for Engagement Events and Discourse
|
Bahri, Priya |
|
|
44 |
11 |
p. 1193-1208 |
article |
9 |
Validating Claims-Based Algorithms Determining Pregnancy Outcomes and Gestational Age Using a Linked Claims-Electronic Medical Record Database
|
Moll, Keran |
|
|
44 |
11 |
p. 1151-1164 |
article |